Financial reports
10-Q
2024 Q1
Quarterly report
23 Apr 24
ARS
2023 FY
Annual report to shareholders
3 Apr 24
10-K
2023 FY
Annual report
22 Feb 24
10-Q
2023 Q3
Quarterly report
25 Oct 23
10-Q
2023 Q2
Quarterly report
27 Jul 23
10-Q
2023 Q1
Quarterly report
4 May 23
10-K
2022 FY
Annual report
23 Feb 23
10-Q
2022 Q3
Quarterly report
27 Oct 22
10-Q
2022 Q2
Quarterly report
27 Jul 22
10-Q
2022 Q1
Quarterly report
28 Apr 22
Current reports
8-K
Results of Operations and Financial Condition
23 Apr 24
8-K
Regulation FD Disclosure
14 Mar 24
8-K
Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2023
22 Feb 24
8-K
Departure of Directors or Certain Officers
29 Dec 23
8-K
Entry into a Material Definitive Agreement
11 Dec 23
8-K
Results of Operations and Financial Condition
25 Oct 23
8-K
Results of Operations and Financial Condition
27 Jul 23
8-K
Option Care Health Confirms Termination of Merger Agreement with Amedisys
26 Jun 23
8-K
Other Events
21 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
19 May 23
Registration and prospectus
RW
Registration withdrawal request
26 Jun 23
425
Business combination disclosure
21 Jun 23
S-4
Registration of securities issued in business combination transactions
5 Jun 23
425
Business combination disclosure
25 May 23
425
Business combination disclosure
17 May 23
425
Business combination disclosure
15 May 23
425
Business combination disclosure
15 May 23
425
Business combination disclosure
9 May 23
425
Business combination disclosure
4 May 23
425
Business combination disclosure
4 May 23
Proxies
DEFA14A
Additional proxy soliciting materials
3 Apr 24
DEF 14A
Definitive proxy
3 Apr 24
DEFA14A
Additional proxy soliciting materials
7 Apr 23
DEF 14A
Definitive proxy
7 Apr 23
DEFA14A
Additional proxy soliciting materials
6 Apr 22
DEF 14A
Definitive proxy
6 Apr 22
DEFA14A
Additional proxy soliciting materials
20 Apr 21
DEFA14A
Additional proxy soliciting materials
7 Apr 21
DEF 14A
Definitive proxy
7 Apr 21
DEFA14A
Additional proxy soliciting materials
10 Apr 20
Other
EFFECT
Notice of effectiveness
9 Jul 20
CORRESP
Correspondence with SEC
6 Jul 20
UPLOAD
Letter from SEC
2 Jul 20
UPLOAD
Letter from SEC
21 Jun 19
CORRESP
Correspondence with SEC
6 Jun 19
UPLOAD
Letter from SEC
28 May 19
UPLOAD
Letter from SEC
30 Aug 17
CORRESP
Correspondence with SEC
15 Aug 17
UPLOAD
Letter from SEC
3 Aug 17
EFFECT
Notice of effectiveness
18 Apr 17
Ownership
3
Femi Adewunmi
23 Apr 24
4
Barbara W. Bodem
3 Apr 24
4
Norman L. Wright
3 Apr 24
4
Luke Whitworth
12 Mar 24
4
Michael Bavaro
1 Mar 24
4
HARRY M JANSEN KRAEMER JR
28 Feb 24
144
Notice of proposed sale of securities
28 Feb 24
4
Christopher L. Grashoff
27 Feb 24
4
MICHAEL H. SHAPIRO
27 Feb 24
4
JOHN CHARLES RADEMACHER
27 Feb 24